Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8302-8322
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Figure 1 Hepatitis B virus upregulated the expression levels of miR-135a-5p in exosomes.
A: Transmission electron microscopy image of exosomes; B: Western blotting indicated proteins in exosomes; C: Analysis of particle size distribution of exosomes; D and E: Quantitative polymerase chain reaction (qPCR) assay examined the expression of miR-135a-5p in exosomes derived from cancer cells and in HCC cell lines; F: Overexpression of Hepatitis B core antigen (HBc) in HepG2 cells was detected by qPCR; G and H: The qRCP assay identified the level of miR-135a-5p in HepG2 cells overexpressed HBc and exosomes isolated from HepG2 cells after transfected with pcDNA3.1-HBc plasmids; I: Detection of miR-135a-5p in adjacent and tumor tissues from 18 patients; J: Expression of miR-135a-5p obtained from TCGA in HCC. aP < 0.05; cP < 0.001. HBc: Hepatitis B core antigen.
- Citation: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322
- URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8302